Literature DB >> 17208427

Deregulated Ras signaling in developmental disorders: new tricks for an old dog.

Suzanne Schubbert1, Gideon Bollag, Kevin Shannon.   

Abstract

Ras proteins regulate cell proliferation, survival and differentiation and are constitutively activated by somatic point mutations in many cancers. Previous studies of neurofibromatosis type 1 and Noonan syndrome also implicated hyperactive Ras in developmental disorders. Recently, germline mutations in H-RAS and K-RAS and in genes encoding other molecules in the Ras-Raf-MEK-ERK cascade were shown to underlie cases of Noonan, cardio-facio-cutaneous, and Costello syndromes. These disorders share phenotypic traits that include abnormal facial features, heart defects, and impaired growth and development. Many of these germline, disease-associated mutations encode novel Ras, Raf and MEK proteins. These studies underscore a crucial role of Ras signaling in human development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17208427     DOI: 10.1016/j.gde.2006.12.004

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  50 in total

Review 1.  Ras and Rap signaling in synaptic plasticity and mental disorders.

Authors:  Ruth L Stornetta; J Julius Zhu
Journal:  Neuroscientist       Date:  2010-04-29       Impact factor: 7.519

Review 2.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 3.  Genetic studies in intellectual disability and related disorders.

Authors:  Lisenka E L M Vissers; Christian Gilissen; Joris A Veltman
Journal:  Nat Rev Genet       Date:  2015-10-27       Impact factor: 53.242

4.  Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.

Authors:  D Aydin; A Bilici; S Kayahan; D Yavuzer; M Basar; M Aliustaoglu
Journal:  Clin Transl Oncol       Date:  2015-10-12       Impact factor: 3.405

5.  Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase.

Authors:  Dana M Gwinn; Alex G Lee; Marcela Briones-Martin-Del-Campo; Crystal S Conn; David R Simpson; Anna I Scott; Anthony Le; Tina M Cowan; Davide Ruggero; E Alejandro Sweet-Cordero
Journal:  Cancer Cell       Date:  2018-01-08       Impact factor: 31.743

Review 6.  Mind the GAP: a role for neurofibromin in restricting axonal plasticity.

Authors:  Andrew D Gaudet; Leanne M Ramer
Journal:  J Neurosci       Date:  2007-05-23       Impact factor: 6.167

7.  Genotype differences in cognitive functioning in Noonan syndrome.

Authors:  E I Pierpont; M E Pierpont; N J Mendelsohn; A E Roberts; E Tworog-Dube; M S Seidenberg
Journal:  Genes Brain Behav       Date:  2008-12-11       Impact factor: 3.449

8.  Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development.

Authors:  Jason Newbern; Jian Zhong; Rasika S Wickramasinghe; Xiaoyan Li; Yaohong Wu; Ivy Samuels; Natalie Cherosky; J Colleen Karlo; Brianne O'Loughlin; Jamie Wikenheiser; Madhusudhana Gargesha; Yong Qiu Doughman; Jean Charron; David D Ginty; Michiko Watanabe; Sulagna C Saitta; William D Snider; Gary E Landreth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

9.  Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome.

Authors:  Hailan Hu; Yi Qin; Genrieta Bochorishvili; Yinghua Zhu; Linda van Aelst; J Julius Zhu
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167

10.  Translocation of H-Ras and its implications in the development of diabetic retinopathy.

Authors:  Renu A Kowluru; Mamta Kanwar
Journal:  Biochem Biophys Res Commun       Date:  2009-07-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.